Septy Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
- Paid Up Capital ₹ 2.17 Cr
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.99 Cr
- Satisfied Charges ₹ 11.03 Cr
- Revenue Growth %
- Ebitda
- Net Worth -0.09%
- Total Assets %
About Septy Pharmaceuticals
Septy Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 May 2006 and has a history of 18 years and eight months. Its registered office is in Assam-781354, Assam.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.17 Cr.
The company currently has active open charges totaling ₹29.99 Cr. The company has closed loans amounting to ₹11.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Saini and Anju Kumari serve as directors at the Company.
Company Details
-
LocationAssam-781354, Assam
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232AS2006PTC008149
-
Company No.
008149
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 May 2006
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
What products or services does Septy Pharmaceuticals Private Limited offer?
Septy Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, IV Fluids, Inorganic Salts, Sodium Chloride NaCl.
Who are the key members and board of directors at Septy Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Saini
|
Director | 07-Mar-2022 | Current |
|
Anju Kumari
|
Director | 15-Mar-2022 | Current |
Financial Performance of Septy Pharmaceuticals.
Septy Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Septy Pharmaceuticals?
In 2023, Septy Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Innocosmetica Wellness LimitedSuresh Saini and Anju Kumari are mutual person
-
Sunlife Biosciences Limited
Suresh Saini and Anju Kumari are mutual person
-
Septy Biosciences Private Limited
Suresh Saini and Anju Kumari are mutual person
-
Anjushree Lifescience Private Limited
Suresh Saini and Anju Kumari are mutual person
-
Alkon Formulation Private Limited
Suresh Saini and Anju Kumari are mutual person
Charges (Loans)
₹29.99 Cr
₹11.03 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 29.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2022 | Hdfc Bank Limited | ₹29.99 Cr | Open |
| 10 Jun 2011 | Assam Gramin Vikash Bank | ₹6.08 Cr | Satisfied |
| 03 Mar 2009 | Allahabad Bank | ₹4.95 Cr | Satisfied |
How Many Employees Work at Septy Pharmaceuticals?
Septy Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Septy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septy Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
